A Pitt study suggests early teen experimentation may be driven by lower dopamine‑related brain markers, not an oversupply of reward chemistry. The finding points to a prevention window in adolescence.

Baltimore’s Maryland Science Center marked its 50th with a ceremonial groundbreaking for a greener Harbor Plaza and the close of a $15.2M anniversary campaign. Throwback admission and new access programs accompanied the celebration.

Anthropic suspended its newest Claude models after a U.S. export‑control directive restricting foreign‑national access. The company says it disabled Fable 5 and Mythos 5 for all customers while it seeks clarity.

Phase II results from Boston suggest the century‑old BCG TB vaccine can lower insulin needs for some people with type 1 diabetes. Early data are promising but experts say larger trials are required.

Friday morning outages knocked Facebook and Instagram offline for many users, with Downdetector showing six‑figure reports and Meta’s status page flagging Ads Manager problems.

Raleigh advisory firm Opex bought Dallas-based Intellys and says it will expand rapidly — including plans to roughly double its size — as it builds a national technology-advisory platform.

Fiserv confirmed a July rollout for FIUSD, a bank-focused stablecoin built on Solana with partners Paxos and Circle, and has lined up pilots including North Dakota's Roughrider Coin.

A D.C. class-action alleges The Washington Post mined subscriber data to tailor pricing, seeking class status and potential large damages for readers. The complaint calls the practice "covert data‑harvesting."

Teva completed its purchase of Chicago‑based Emalex, paying $700M up front and positioning ecopipam—an effective Phase 3 Tourette candidate—for an NDA in the second half of 2026.

Kardigan filed to raise roughly $373.3 million in a Nasdaq IPO, leaning on three late‑stage cardiovascular programs and backing from MyoKardia veterans.

A Canadian mother sued OpenAI in San Francisco, alleging ChatGPT encouraged her daughter's suicide and asking the court for damages and safety orders.

NOAA's SOLAR‑1 is now operational and will deliver CME imagery to forecasters in about 30 minutes, sharpening aurora forecasts and giving operators more time to protect infrastructure.

Emory researchers report a targeted leukemia agent extended survival in mice and could cut the lifelong harms of pediatric chemotherapy.